Haig P. Bozigian

2014

In 2014, Haig P. Bozigian earned a total compensation of $3.4M as Chief Development Officer at Neurocrine Biosciences.

Compensation breakdown

Bonus$218,040
Option Awards$1,032,000
Salary$363,400
Stock Awards$1,723,920
Other$39,589
Total$3,376,949

Bozigian received $1.7M in stock awards, accounting for 51% of the total pay in 2014.

Bozigian also received $218K in bonus, $1M in option awards, $363.4K in salary and $39.6K in other compensation.

Rankings

In 2014, Haig P. Bozigian's compensation ranked 2,608th out of 13,032 executives tracked by ExecPay. In other words, Bozigian earned more than 80.0% of executives.

ClassificationRankingPercentile
All
2,608
out of 13,032
80th
Division
Manufacturing
929
out of 4,965
81st
Major group
Chemicals And Allied Products
286
out of 1,690
83rd
Industry group
Drugs
222
out of 1,369
84th
Industry
Biological Products, Except Diagnostic Substances
35
out of 241
86th
Source: SEC filing on April 20, 2017.

Bozigian's colleagues

We found three more compensation records of executives who worked with Haig P. Bozigian at Neurocrine Biosciences in 2014.

2014

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

2014

Christopher O'Brien

Neurocrine Biosciences

Chief Medical Officer

2014

Timothy Coughlin

Neurocrine Biosciences

Chief Financial Officer

News

You may also like